companies developing glp 1 drugs GLP-1 Revolution Transforms Obesity Treatment | Siddhi Patil posted on the topic FDA says that the GLP-1
Description
Approved for weight management as Saxenda, it requires daily injections rather than weekly, which is a significant practical difference
GLP-1 RAs have been shown to induce phosphorylation and inactivation of NHE3 (Muskiet et al., 2017)
Drucker, J.J
Tirzepatide, a dual-action medication targeting both GIP and GLP-1 receptors, offers potentially superior metabolic benefits
Compounded versions are not FDA-approved and haven't undergone the same clinical testing as brand-name GLP-1 medications
